Trials / Completed
CompletedNCT06113874
The Influence of Desensitizing Agent on Postoperative Sensitivity in Posterior Composite Restoration
The Influence of Desensitizing Agent on Postoperative Sensitivity in Posterior Composite Restoration: A Randomized Controlled Clinical Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Nourhan M.Aly · Academic / Other
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to investigate the influence of desensitizing agents on reducing post-operative sensitivity in posterior composite.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Hurriseal desensitizer | Patients will receive Hurriseal desensitizing agent and universal bond and composite. Cavities will be restored with light-cured composite resin following the application of bonding agent. |
| OTHER | Gluma desensitizer | Patients will receive Gluma desensitizing agent and universal bond and composite. Cavities will be restored with light-cured composite resin following the application of bonding agent. |
Timeline
- Start date
- 2022-07-05
- Primary completion
- 2023-08-05
- Completion
- 2023-08-30
- First posted
- 2023-11-02
- Last updated
- 2023-11-02
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06113874. Inclusion in this directory is not an endorsement.